+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Tumor Therapeutics Market by Therapeutic Approach, Product Type, Tumor Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Brain Tumor Therapeutics Market by Therapeutic Approach, Product Type, Tumor Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Brain Tumor Therapeutics Market by Therapeutic Approach, Product Type, Tumor Type, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011114
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The brain tumor therapeutics market is experiencing continuous transformation, with technology innovation and clinical demand reshaping competitive and regulatory environments. For decision-makers, understanding this complex landscape is crucial for effective planning, resource allocation, and market positioning.

Market Snapshot: Brain Tumor Therapeutics Market Overview

The Brain Tumor Therapeutics Market grew from USD 3.28 billion in 2024 to USD 3.56 billion in 2025. It is expected to continue growing at a CAGR of 8.27%, reaching USD 5.28 billion by 2030. Rising disease incidence, expanding access to advanced treatments, and new modalities such as immunotherapy and targeted agents are fueling sustained growth. Industry momentum is further driven by regulatory activity, investment in novel therapeutic platforms, and technology integration, with cross-disciplinary collaboration accelerating progress. Regional development strategies and evolving cost structures demand a vigilant approach to market access and reimbursement.

Scope & Segmentation

This report provides a comprehensive analysis of the brain tumor therapeutics industry across core product and regional dimensions. Segmentation is as follows:

  • Therapeutic Approach: Chemotherapy (alkylating agents, antimetabolites, plant alkaloids), Immunotherapy (CAR T, checkpoint inhibitors, vaccines), Radiotherapy (brachytherapy, external beam, stereotactic radiosurgery), Surgery (craniotomy, stereotactic surgery), Targeted Therapy (monoclonal antibodies, small molecules)
  • Product Type: Devices (imaging equipment, radiation equipment, surgical instruments), Pharmaceuticals (chemotherapeutic drugs, immunotherapeutics, targeted drugs)
  • Tumor Type: Astrocytoma, Glioblastoma, Meningioma
  • End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
  • Distribution Channel: Hospital pharmacies, Online pharmacies, Retail pharmacies
  • Geography: Americas (United States with detailed state-level analysis, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major countries in Western and Eastern regions), and Asia-Pacific (comprehensive country coverage from Japan and China through Southeast Asia and Australia)
  • Key Companies: Merck & Co., F. Hoffmann-La Roche, Novocure, Bristol-Myers Squibb, Pfizer, AbbVie, AstraZeneca, Novartis, Teva, and GlaxoSmithKline

Key Takeaways for Senior Leaders

  • Technological innovation is unlocking new treatment paradigms, especially with the growing adoption of immunotherapy, precision diagnostics, and minimally invasive surgical techniques.
  • Strategic partnerships between device developers and pharmaceutical innovators are accelerating the development and commercialization of complementary regimens and combination therapies.
  • Regional heterogeneity affects market adoption; North America and major Asia-Pacific countries see the most robust uptake, while infrastructure and access pose challenges in select regions.
  • Competitive dynamics are shifting, with both established pharmaceutical leaders and specialized biotechs actively consolidating expertise in cross-functional platforms and pipeline diversification.
  • Differentiation is increasingly reliant on integrated solutions encompassing diagnostics, therapeutics, and follow-up care, supported by real-world evidence and health outcome analytics.

Tariff Impact and Regulatory Response

New tariff measures in the United States set for 2025 will impact the importation of both pharmaceutical ingredients and specialized medical devices in brain tumor care. These tariffs are likely to influence procurement strategies, manufacturing partnerships, and patient access, prompting the need for proactive cost-management and negotiation with payers. Regulatory adaptation and engagement will be central as these policies shape future supply dynamics and cost structures.

Methodology & Data Sources

This report integrates primary and secondary research, including expert interviews with neuro-oncologists, regulatory stakeholders, and payers. Data is triangulated across validated industry databases, financial reports, peer-reviewed literature, and direct market inputs, ensuring a high degree of reliability and insight.

Why This Report Matters

  • Enables leaders to prioritize investments, research, and development aligned to emerging market needs and regulatory shifts.
  • Provides actionable segmentation and regional intelligence to guide strategic expansion or risk mitigation efforts.
  • Supports evidence-based decision-making by marrying clinical advancements with economic, competitive, and policy developments.

Conclusion

Evolving clinical strategies, shifting tariffs, and an active competitive landscape are redefining the brain tumor therapeutics market. This report delivers essential intelligence for decision-makers to drive innovation and sustain growth within an increasingly complex environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Brain Tumor Therapeutics Market, by Therapeutic Approach
8.1. Introduction
8.2. Chemotherapy
8.2.1. Alkylating Agents
8.2.2. Antimetabolites
8.2.3. Plant Alkaloids
8.3. Immunotherapy
8.3.1. CAR T
8.3.2. Checkpoint Inhibitors
8.3.3. Vaccines
8.4. Radiotherapy
8.4.1. Brachytherapy
8.4.2. External Beam Radiotherapy
8.4.3. Stereotactic Radiosurgery
8.5. Surgery
8.5.1. Craniotomy
8.5.2. Stereotactic Surgery
8.6. Targeted Therapy
8.6.1. Monoclonal Antibodies
8.6.2. Small Molecules
9. Brain Tumor Therapeutics Market, by Product Type
9.1. Introduction
9.2. Devices
9.2.1. Imaging Equipment
9.2.2. Radiation Equipment
9.2.3. Surgical Instruments
9.3. Pharmaceutical
9.3.1. Chemotherapeutic Drugs
9.3.2. Immunotherapeutics
9.3.3. Targeted Drugs
10. Brain Tumor Therapeutics Market, by Tumor Type
10.1. Introduction
10.2. Astrocytoma
10.3. Glioblastoma
10.4. Meningioma
11. Brain Tumor Therapeutics Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Specialty Clinics
12. Brain Tumor Therapeutics Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Americas Brain Tumor Therapeutics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Brain Tumor Therapeutics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Brain Tumor Therapeutics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. F. Hoffmann-La Roche Ltd.
16.3.3. Novocure Ltd.
16.3.4. Bristol-Myers Squibb Company
16.3.5. Pfizer Inc.
16.3.6. AbbVie Inc.
16.3.7. AstraZeneca plc
16.3.8. Novartis AG
16.3.9. Teva Pharmaceutical Industries Ltd.
16.3.10. GlaxoSmithKline plc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BRAIN TUMOR THERAPEUTICS MARKET MULTI-CURRENCY
FIGURE 2. BRAIN TUMOR THERAPEUTICS MARKET MULTI-LANGUAGE
FIGURE 3. BRAIN TUMOR THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BRAIN TUMOR THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BRAIN TUMOR THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BRAIN TUMOR THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PLANT ALKALOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CAR T, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CRANIOTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STEREOTACTIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIATION EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPEUTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ASTROCYTOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 80. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 81. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 82. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 83. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 84. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 85. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 87. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 88. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 89. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 153. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 157. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 158. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 160. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 161. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 162. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 165. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 166. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 167. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 168. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 169. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 173. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 189. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 190. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 191. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 192. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 193. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 194. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 196. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 197. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 198. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 201. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 202. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 203. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 204. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 205. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 206. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 208. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 209. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 210. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. SPAIN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 249. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 250. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 251. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 252. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 253. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 254. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 256. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 257. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 258. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. DENMARK BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 273. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 274. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 275. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 276. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 277. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 278. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 280. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 281. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 282. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. QATAR BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 285. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 286. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 287. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 288. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 289. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 290. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 292. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 293. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 294. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. FINLAND BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. SWEDEN BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 316. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 317. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 318. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. NIGERIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 320. EGYPT BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 321. EGYPT BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 322. EGYPT BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 323. EGYPT BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 324. EGYPT BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Brain Tumor Therapeutics market report include:
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novocure Ltd.
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • AbbVie Inc.
  • AstraZeneca plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.28 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Brain Tumor Diagnosis & Treatment Market by Treatment Type, Diagnosis Type, End User, Tumor Type - Global Forecast to 2030 - Product Image

Brain Tumor Diagnosis & Treatment Market by Treatment Type, Diagnosis Type, End User, Tumor Type - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Brain Tumor Diagnosis & Therapeutics Market by Therapeutic Modality, Imaging Technology, End User, Tumor Type, Tumor Grade, Patient Age Group - Global Forecast to 2030 - Product Image

Brain Tumor Diagnosis & Therapeutics Market by Therapeutic Modality, Imaging Technology, End User, Tumor Type, Tumor Grade, Patient Age Group - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Brain Tumor Diagnosis and Therapeutics Market Size, Share & Trends Analysis Report by Type (Primary, Secondary), Product, Diagnosis (MRI, CT, PET-CT), Therapeutics, End Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Brain Tumor Diagnosis and Therapeutics Market Size, Share & Trends Analysis Report by Type (Primary, Secondary), Product, Diagnosis (MRI, CT, PET-CT), Therapeutics, End Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Brain Tumor Therapeutics - Global Strategic Business Report - Product Image

Brain Tumor Therapeutics - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
Brain Tumor Diagnosis and Treatment - Global Strategic Business Report - Product Image

Brain Tumor Diagnosis and Treatment - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.